Results
1 -
9 of
9
(Click
here to explore results)
- Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Xiu-Xiu Wang, Si-Yu Sun, Qing-Qing Dong, Xiao-Xiang Wu, Wei Tang, Ya-Qun Xing
, Med. Chem. Commun.
, 2019
, 10
, 1740
- Current status of controlled onco-therapies based on metal organic frameworks. Yixuan Yang, Xiaofeng Dai
, RSC Adv.
, 2024
, 14
, 12817
- Surface functionalization of metal–organic framework nanoparticle for overcoming biological barrier in cancer therapy. Jun Yong Oh, Youjung Sim, Gyeongseok Yang, Myoung-Hwan Park, Kibeom Kim, Ja-Hyoung Ryu
, Inorg. Chem. Front.
, 2024
, 11
, 3119
- Microfluidic platforms for extracellular vesicle isolation, analysis and therapy in cancer. Catarina M. Abreu, Bruno Costa-Silva, Rui L. Reis, Subhas C. Kundu, David Caballero
, Lab Chip
, 2022
, 22
, 1093
- Recent insights of PROTAC developments in inflammation-mediated and autoimmune targets: a critical review. Mary Sravani Galla, Nitika Sharma, Priyanka Mishra, Nagula Shankaraiah
, RSC Med. Chem.
, 2024
- A polymeric IDO inhibitor based on poly(ethylene glycol)-b-poly(l-tyrosine-co-1-methyl-d-tryptophan) enables facile trident cancer immunotherapy. Yuanyuan Liu, Jiguo Xie, Xiaofei Zhao, Yueyue Zhang, Zhiyuan Zhong, Chao Deng
, Biomater. Sci.
, 2022
, 10
, 5731
- Vinylazaarenes as dienophiles in Lewis acid-promoted Diels–Alder reactions. Anna E. Davis, Jared M. Lowe, Michael K. Hilinski
, Chem. Sci.
, 2021
, 12
, 15947
- Design, synthesis and bioevaluation of novel 6-substituted aminoindazole derivatives as anticancer agents. Ngo Xuan Hoang, Van-Hai Hoang, Thi-Thu-Trang Luu, Hung N. Luu, Thien Ngo, Duong Van Hieu, Nguyen Huu Long, Le Viet Anh, Son Tung Ngo, Yen Thi Kim Nguyen, Byung Woo Han, Thanh Xuan Nguyen, Dinh Thi Thanh Hai, Tran Thi Thu Hien, Phuong-Thao Tran
, RSC Adv.
, 2020
, 10
, 45199
- Boron reagents for divergent radiochemistry. Thomas C. Wilson, Thomas Cailly, Véronique Gouverneur
, Chem. Soc. Rev.
, 2018
, 47
, 6990